Clotilde Duquenne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Clotilde Duquenne has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Gabriel Livera
Stabilité Génétique, Cellules Souches et Radiations, LDG/IRCM/IBFJ, CEA, Université Paris Cité, 92260 Fontenay-aux-Roses, France
4 shared publications - René Habert
Laboratory of Development of the Gonads, UMR-008 Genetic Stability Stem Cells and Radiations, Université de Paris, 92265 Fontenay-aux-Roses, France
3 shared publications Nelly Frydman
2 shared publicationsAlexandra Benachi
1 shared publicationBenoit Robert
1 shared publicationBenoit Souquet
1 shared publication
Latest Publications
- Open Access
MEIOB and SPATA22 resemble RPA subunits and interact with the RPA complex to promote meiotic recombination
Homologous recombination is a conserved DNA repair process mandatory for chromosome segregation during meiosis. RPA, a ubiquitous complex essential to recombination, is thought to play a similar role during mitotic and meiotic recombination. MEIOB, a meiosis-specific factor with unknown molecular function, ressembles a RPA subunit. Here we use in vivo approaches to show that in mouse spermatocytes, DMC1 and RAD51 appear to be normally loaded in the absence of MEIOB but are prematurely lost from unrepaired recombination sites. This loss correlates with an accumulation of the BLM helicase on meiotic chromosomes. We also show that MEIOB alters the immunodetection of RPA subunits at meiotic recombination sites. Using electron microscopy and purified proteins, we demonstrate that the MEIOB-SPATA22 complex associates with and modifies the conformation of RPA-coated ssDNA. Finally, we identify structural homology between MEIOB, SPATA22 and RPA subunits, and show that MEIOB and SPATA22 interact through C-terminal OB-fold containing domains (OBCDs) like RPA subunits. Moreover, MEIOB and SPATA22 cooperate to interact with RPA through their OBCDs. Our results suggest that MEIOB, SPATA22 and RPA work together to ensure proper processing of meiotic recombination intermediates.
Open AccessMEIOB and SPATA22 resemble RPA subunits and interact with the RPA complex to promote meiotic recombination
Homologous recombination is a conserved DNA repair process mandatory for chromosome segregation during meiosis. RPA, a ubiquitous complex essential to recombination, is thought to play a similar role during mitotic and meiotic recombination. MEIOB, a meiosis-specific factor with unknown molecular function, ressembles a RPA subunit. Here we use in vivo approaches to show that in mouse spermatocytes, DMC1 and RAD51 appear to be normally loaded in the absence of MEIOB but are prematurely lost from unrepaired recombination sites. This loss correlates with an accumulation of the BLM helicase on meiotic chromosomes. We also show that MEIOB alters the immunodetection of RPA subunits at meiotic recombination sites. Using electron microscopy and purified proteins, we demonstrate that the MEIOB-SPATA22 complex associates with and modifies the conformation of RPA-coated ssDNA. Finally, we identify structural homology between MEIOB, SPATA22 and RPA subunits, and show that MEIOB and SPATA22 interact through C-terminal OB-fold containing domains (OBCDs) like RPA subunits. Moreover, MEIOB and SPATA22 cooperate to interact with RPA through their OBCDs. Our results suggest that MEIOB, SPATA22 and RPA work together to ensure proper processing of meiotic recombination intermediates.
- 23 September 2014
- Published by Bioscientifica in Reproduction Abstracts
Inhibition of DMRTA2 impairs human female germline development in xeno-grafted ovaries
Context: DMRTA2 belongs to a family of genes coding for proteins containing a DM-domain that are conserved among vertebrates and widely involved in gonadal differentiation. We recently identified Dmrta2 gene expression through transcriptome analysis performed in murine female embryonic germ cells and retrieved its expression in human fetal ovaries. The role of DMRTA2 is poorly documented and we thus conducted this study to clarify its implication in human fetal ovaries. Material and methods: Human fetal ovaries (8 – 11 weeks post fertilization) were harvested from material available following legally induced abortions and were grafted in two immunodeficient NMRI:Nu/Nu mice. Recipient mice were treated with siRNA targeting specifically the sequence of human DMRTA2. Results and discussion: The xenograft model did recapitulate all the stages of female germ cell development with no overt change when compared to ungrafted ovaries. After 10 days of treatment with siRNA, we observed of robust inhibition of DMRTA2. This inhibition did not alter germ cell density or apoptosis. RT-qPCR and immunostaining analyses indicated that the expression of markers of undifferentiated germ cells was unchanged while the expression of markers of differentiating, pre-meiotic and meiotic germ cells were systematically decreased. This study reveals for the first time the requirement of DMRTA2 for the normal development of human female embryonic germ cells. DMRTA2 appears required to allow the differentiation of oogonia shortly prior their entry into meiosis. Additionally, we set up an original model of xenograft that should prove useful for future investigations of the human germline development. The mammalian target of rapamycin (mTOR) signaling pathway functions as a central regulator of cell growth, proliferation, and survival. We previously reported that during meiotic maturation, the expression levels of mTOR in oocytes remain similar from the germinal vesicle (GV) stage to metaphase II (MII). To investigate the role played by mTOR during meiotic resumption, we cultured murine cumulus – oocyte complexes (COCs) in the presence of mTOR inhibitors. mTOR expression was detected in the cumulus cells. The COCs were cultured for 18 h in a medium containing dbcAMP with or without the mTOR inhibitor PI-103 or rapamycin. We observed cumulus expansion but the oocytes were arrested at the GV stage. These oocytes were then transferred to fresh maturation medium containing FSH with or without an mTOR inhibitor before culturing for 8 more hours. We found premature development of the first polar body in oocytes treated with the mTOR inhibitor. This result suggests that mTOR inhibition induces early progression of oocytes. Further, when GV-stage oocytes were cultured for 18 h in maturation medium lacking FSH but containing the mTOR inhibitor PI-103 or rapamycin, the cumulus cells expanded and the first polar body successfully developed. In addition, we found that the mRNA expression of hyaluronan synthase (HAS) in the cumulus cells increased after treatment with the mTOR inhibitor. In conclusion, our data suggest a role for mTOR signaling during cumulus expansion and meiotic maturation in mice. In the presence of an mTOR inhibitor, cumulus expansion occurred and meiotic maturation progressed without gonadotropin stimulation.
- 23 September 2014
- Published by Bioscientifica in Reproduction Abstracts
Inhibition of DMRTA2 impairs human female germline development in xeno-grafted ovaries
Context: DMRTA2 belongs to a family of genes coding for proteins containing a DM-domain that are conserved among vertebrates and widely involved in gonadal differentiation. We recently identified Dmrta2 gene expression through transcriptome analysis performed in murine female embryonic germ cells and retrieved its expression in human fetal ovaries. The role of DMRTA2 is poorly documented and we thus conducted this study to clarify its implication in human fetal ovaries. Material and methods: Human fetal ovaries (8 – 11 weeks post fertilization) were harvested from material available following legally induced abortions and were grafted in two immunodeficient NMRI:Nu/Nu mice. Recipient mice were treated with siRNA targeting specifically the sequence of human DMRTA2. Results and discussion: The xenograft model did recapitulate all the stages of female germ cell development with no overt change when compared to ungrafted ovaries. After 10 days of treatment with siRNA, we observed of robust inhibition of DMRTA2. This inhibition did not alter germ cell density or apoptosis. RT-qPCR and immunostaining analyses indicated that the expression of markers of undifferentiated germ cells was unchanged while the expression of markers of differentiating, pre-meiotic and meiotic germ cells were systematically decreased. This study reveals for the first time the requirement of DMRTA2 for the normal development of human female embryonic germ cells. DMRTA2 appears required to allow the differentiation of oogonia shortly prior their entry into meiosis. Additionally, we set up an original model of xenograft that should prove useful for future investigations of the human germline development. The mammalian target of rapamycin (mTOR) signaling pathway functions as a central regulator of cell growth, proliferation, and survival. We previously reported that during meiotic maturation, the expression levels of mTOR in oocytes remain similar from the germinal vesicle (GV) stage to metaphase II (MII). To investigate the role played by mTOR during meiotic resumption, we cultured murine cumulus – oocyte complexes (COCs) in the presence of mTOR inhibitors. mTOR expression was detected in the cumulus cells. The COCs were cultured for 18 h in a medium containing dbcAMP with or without the mTOR inhibitor PI-103 or rapamycin. We observed cumulus expansion but the oocytes were arrested at the GV stage. These oocytes were then transferred to fresh maturation medium containing FSH with or without an mTOR inhibitor before culturing for 8 more hours. We found premature development of the first polar body in oocytes treated with the mTOR inhibitor. This result suggests that mTOR inhibition induces early progression of oocytes. Further, when GV-stage oocytes were cultured for 18 h in maturation medium lacking FSH but containing the mTOR inhibitor PI-103 or rapamycin, the cumulus cells expanded and the first polar body successfully developed. In addition, we found that the mRNA expression of hyaluronan synthase (HAS) in the cumulus cells increased after treatment with the mTOR inhibitor. In conclusion, our data suggest a role for mTOR signaling during cumulus expansion and meiotic maturation in mice. In the presence of an mTOR inhibitor, cumulus expansion occurred and meiotic maturation progressed without gonadotropin stimulation.
- 15 December 2011
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 124 (24) , e1
Msx1 and Msx2 promote meiosis initiation
- 15 December 2011
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 124 (24) , e1
Msx1 and Msx2 promote meiosis initiation
- 1 March 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (5) , 656-664
Retinoic acid prevents germ cell mitotic arrest in mouse fetal testes
During mouse fetal development, meiosis is initiated in female germ cells only, with male germ cells undergoing mitotic arrest. Retinoic acid (RA) is degraded by Cyp26b1 in the embryonic testis but not in the ovary where it initiates the mitosis/meiosis transition. However the role of RA status in fetal germ cell proliferation has not been elucidated. As expected, using organ cultures, we observed that addition of RA in 11.5 days post-conception (dpc) testes induced Stra8 expression and meiosis. Surprisingly, in 13.5 dpc testes although RA induced Stra8 expression it did not promote meiosis. On 11.5 and 13.5 dpc, RA prevented male germ cell mitotic arrest through PI3K signaling. Therefore 13.5 dpc testes appeared as an interesting model to investigate RA effects on germ cell proliferation/differentiation independently of RA effect on the meiosis induction. At this stage, RA delayed SSEA-1 extinction, p63γ expression and DNA hypermethylation which normally occur in male mitotic arrested germ cells. In vivo, in the fetal male gonad, germ cells cease their proliferation and loose SSEA-1 earlier than in female gonad and RA administration maintained male germ cell proliferation. Lastly, inhibition of endogenous Cyp26 activity in 13.5 dpc cultured testes also prevented male germ cell mitotic arrest. Our data demonstrate that the reduction of RA levels, which occurs specifically in the male fetal gonad and was known to block meiosis initiation, is also necessary to allow the establishment of the germ cell mitotic arrest and the correct further differentiation of the fetal germ cells along the male pathway.
- 1 March 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (5) , 656-664
Retinoic acid prevents germ cell mitotic arrest in mouse fetal testes
During mouse fetal development, meiosis is initiated in female germ cells only, with male germ cells undergoing mitotic arrest. Retinoic acid (RA) is degraded by Cyp26b1 in the embryonic testis but not in the ovary where it initiates the mitosis/meiosis transition. However the role of RA status in fetal germ cell proliferation has not been elucidated. As expected, using organ cultures, we observed that addition of RA in 11.5 days post-conception (dpc) testes induced Stra8 expression and meiosis. Surprisingly, in 13.5 dpc testes although RA induced Stra8 expression it did not promote meiosis. On 11.5 and 13.5 dpc, RA prevented male germ cell mitotic arrest through PI3K signaling. Therefore 13.5 dpc testes appeared as an interesting model to investigate RA effects on germ cell proliferation/differentiation independently of RA effect on the meiosis induction. At this stage, RA delayed SSEA-1 extinction, p63γ expression and DNA hypermethylation which normally occur in male mitotic arrested germ cells. In vivo, in the fetal male gonad, germ cells cease their proliferation and loose SSEA-1 earlier than in female gonad and RA administration maintained male germ cell proliferation. Lastly, inhibition of endogenous Cyp26 activity in 13.5 dpc cultured testes also prevented male germ cell mitotic arrest. Our data demonstrate that the reduction of RA levels, which occurs specifically in the male fetal gonad and was known to block meiosis initiation, is also necessary to allow the establishment of the germ cell mitotic arrest and the correct further differentiation of the fetal germ cells along the male pathway.